Table 3 Amount of immunopositive cells at the lesion epicentre at different survival times following human SCI
From: Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
|  | Control | 2 days | 4–5 days | 8 days | 10–11 days | 24 days | 4 months |
|---|---|---|---|---|---|---|---|
CD68 | 0/+ | + | +++ | ++++ | ++++ | ++++ | ++ |
MMP-1 | + | + | ++ | +++ | + | + | + (astrocytes) |
MMP-2 | 0 | + | ++ | +++ | ++ | + | 0 |
MMP-9 | 0/+ | + | ++ | +++ | +++ | +++ | 0/+ |
MMP-12 | 0 | + | + | + | + | ++++ | 0 |
TIMP-1 | 0 | 0/+ | 0/+ | 0/+ | 0/+ | 0/+ | 0 |
TIMP-2 | + | 0/+ | 0/+ | 0/+ | 0/+ | 0/+ | + |
TIMP-3 | 0/+ | 0/+ | 0/+ | 0/+ | 0/+ | 0/+ | 0/+ |